These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24194751)

  • 1. Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation.
    Wang Z; Wu J; Zhang G; Cao Y; Jiang C; Ding Y
    Gastroenterol Res Pract; 2013; 2013():719202. PubMed ID: 24194751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
    Yu JY; Hu F; Du W; Ma XL; Yuan K
    J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis.
    Liang TJ; Liu HJ; Zhao XQ; Yu CH; Li CS
    PLoS One; 2013; 8(7):e68588. PubMed ID: 23935875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
    PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.
    Tao T; Chen S; Xu B; Liu C; Wang Y; Huang Y; Chen M
    Chin J Cancer Res; 2014 Jun; 26(3):315-22. PubMed ID: 25035659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
    Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
    Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
    Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
    Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S
    Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis.
    Zhang Q; Xu X; Wu M; Qin T; Wu S; Liu H
    Front Oncol; 2020; 10():562019. PubMed ID: 33542895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y
    PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between miR-34b/c rs4938723 polymorphism and risk of cancer: An updated meta-analysis of 27 case-control studies.
    Hashemi M; Moazeni-Roodi A; Bahari G; Taheri M; Ghavami S
    J Cell Biochem; 2019 Mar; 120(3):3306-3314. PubMed ID: 30203457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.
    Liu CJ; Ma XW; Zhang XJ; Shen SQ
    Int J Mol Epidemiol Genet; 2017; 8(1):1-7. PubMed ID: 28337312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects.
    Jiang JK; Chen HS; Tang WF; Chen Y; Lin J
    World J Gastrointest Oncol; 2023 Jan; 15(1):171-185. PubMed ID: 36684045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
    Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
    Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers.
    Li L; Zhu J; Lu T; Liu W; Tang J; Zhang J; Wang Y; Li Y; Li S; Zhou H; Xia H; He J; Cheng J
    Transl Oncol; 2019 Oct; 12(10):1282-1288. PubMed ID: 31325764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma.
    Yu H; Wang Y; Wang S; Sun N
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):42-5. PubMed ID: 27453271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
    Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
    J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis.
    Wang BG; Jiang LY; Xu Q
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29976775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis.
    Zhu SL; Zhong JH; Gong WF; Li H; Li LQ
    Onco Targets Ther; 2016; 9():2111-9. PubMed ID: 27143913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: An updated meta-analysis.
    Zheng L; Zhuang C; Zhao J; Ming L
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):664-676. PubMed ID: 28499985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.